A partner in the firm’s IP group, Chris Cowles focuses his practice on biotechnology patent preparation and prosecution across RNA interference (RNAi), antibody, microbiology, virology, cell biology, and genomic technologies. He also provides strategic IP counsel to academic and biotech industry clients on domestic and international IP portfolio management. He is experienced in the preparation and prosecution of US and foreign patent applications related to biotechnology and biochemistry, including the fields of oligonucleotide therapeutics, cell biology, and genomics. His experience also includes IP due diligence and the preparation of noninfringement, invalidity, and freedom-to-operate opinions.